Superior in vitro biocompatibility of a six-arm sPEG-based tissue adhesive and its ex vivo sealing performance in a 3R-compliant porcine intestinal perfusion model

Introduction Anastomotic leakage remains one of the most serious complications following gastrointestinal surgery and is associated with substantial morbidity and mortality. Although tissue adhesives have been proposed to reinforce intestinal anastomoses, their preclinical evaluation still relies largely on animal models with limited translational relevance and ethical concerns. This study aimed to evaluate a six-armed star-shaped polyethylene oxide-stat-propylene oxide tissue adhesive (sPEG) using a comprehensive 3R-compliant bioevaluation platform combining standardized in vitro testing with a dynamic ex vivo porcine intestinal perfusion model. Methods The cytocompatibility and hemocompatibility of sPEG were assessed according to DIN EN ISO 10993 using human dermal fibroblasts and human blood-derived assays. Performance was benchmarked against the clinically established tissue adhesives DERMABOND™ and TISSEEL TM . Sealing efficacy was evaluated in a custom-developed ex vivo porcine small-intestine perfusion model employing intestinal segments ≥15 cm exposed to continuous intraluminal flow for 24 h under physiologically relevant conditions. Leakage volume, time to first leakage, and drop rate were recorded. Results DERMABOND TM extracts induced significant cytotoxicity, whereas TISSEEL TM and sPEG showed no relevant cytotoxic effects. All three materials exhibited negligible hemolysis. Thrombocyte adhesion was minimal on sPEG, intermediate on DERMABOND TM , and pronounced on TISSEEL TM . In the ex vivo perfusion model, sPEG prevented detectable leakage throughout the entire 24 h observation period and demonstrated a drop rate of 0 drops/h. DERMABOND TM and TISSEEL TM exhibited leakage during perfusion, with TISSEEL TM showing the weakest sealing performance. DERMABOND TM provided relatively good mechanical sealing but was associated with marked cytotoxicity. Overall, sPEG combined effective sealing performance with excellent biological compatibility. Discussion The presented platform enables physiologically relevant and ethically responsible preclinical assessment of intestinal tissue adhesives by integrating standardized biocompatibility testing with continuous-flow ex vivo perfusion. Within this framework, the six-armed sPEG adhesive demonstrated a favorable combination of cytocompatibility, hemocompatibility, and sealing efficacy superior to the clinically used comparators. These findings identify sPEG as a promising candidate for further translational development and establish the presented ex vivo model as a versatile 3R-compliant screening platform for next-generation intestinal sealants.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2026-11-17
DOI
https://doi.org/10.3389/fbioe.2026.1936249
Primary Topic
Surgical Sutures and Adhesives
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Superior in vitro biocompatibility of a six-arm sPEG-based tissue adhesive and its ex vivo sealing performance in a 3R-compliant porcine intestinal perfusion model

Ulrik Stervbo, Nina Babel, Richard Viebahn, Jochen Salber et al.
1 links
Frontiers in Bioengineering and Biotechnology
Surgical Sutures and Adhesives
article

Superior in vitro biocompatibility of a six-arm sPEG-based tissue adhesive and its ex vivo sealing performance in a 3R-compliant porcine intestinal perfusion model

Ulrik Stervbo, Nina Babel, Richard Viebahn, Jochen Salber, Alexander Sieberath, Dierk Gruhn, Juergen Groll, Björn L. D. M. Brücher, Lea Zittlau
article en

Abstract

Introduction Anastomotic leakage remains one of the most serious complications following gastrointestinal surgery and is associated with substantial morbidity and mortality. Although tissue adhesives have been proposed to reinforce intestinal anastomoses, their preclinical evaluation still relies largely on animal models with limited translational relevance and ethical concerns. This study aimed to evaluate a six-armed star-shaped polyethylene oxide-stat-propylene oxide tissue adhesive (sPEG) using a comprehensive 3R-compliant bioevaluation platform combining standardized in vitro testing with a dynamic ex vivo porcine intestinal perfusion model. Methods The cytocompatibility and hemocompatibility of sPEG were assessed according to DIN EN ISO 10993 using human dermal fibroblasts and human blood-derived assays. Performance was benchmarked against the clinically established tissue adhesives DERMABOND™ and TISSEEL TM . Sealing efficacy was evaluated in a custom-developed ex vivo porcine small-intestine perfusion model employing intestinal segments ≥15 cm exposed to continuous intraluminal flow for 24 h under physiologically relevant conditions. Leakage volume, time to first leakage, and drop rate were recorded. Results DERMABOND TM extracts induced significant cytotoxicity, whereas TISSEEL TM and sPEG showed no relevant cytotoxic effects. All three materials exhibited negligible hemolysis. Thrombocyte adhesion was minimal on sPEG, intermediate on DERMABOND TM , and pronounced on TISSEEL TM . In the ex vivo perfusion model, sPEG prevented detectable leakage throughout the entire 24 h observation period and demonstrated a drop rate of 0 drops/h. DERMABOND TM and TISSEEL TM exhibited leakage during perfusion, with TISSEEL TM showing the weakest sealing performance. DERMABOND TM provided relatively good mechanical sealing but was associated with marked cytotoxicity. Overall, sPEG combined effective sealing performance with excellent biological compatibility. Discussion The presented platform enables physiologically relevant and ethically responsible preclinical assessment of intestinal tissue adhesives by integrating standardized biocompatibility testing with continuous-flow ex vivo perfusion. Within this framework, the six-armed sPEG adhesive demonstrated a favorable combination of cytocompatibility, hemocompatibility, and sealing efficacy superior to the clinically used comparators. These findings identify sPEG as a promising candidate for further translational development and establish the presented ex vivo model as a versatile 3R-compliant screening platform for next-generation intestinal sealants.

Frontiers in Bioengineering and BiotechnologyVol. 14
University of Würzburg (DE), University Hospitals of the Ruhr-University of Bochum (DE), Universitätsklinik Marien Hospital Herne (DE), Universitätsklinikum Knappschaftskrankenhaus Bochum (DE), Medizinische Universität Lausitz - Carl Thiem (DE), Bavarian Polymer Institute (DE), Ruhr University Bochum (DE)
Good health and well-being
Surgical Sutures and Adhesives
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon